The price of XAIR is predicted to go up 7.8%, based on the high correlation periods with XPO. The similarity of these two price pattern on the periods is 94%.

XAIR

XPO

Up: 7.8%Similarity: 94%

XAIR Revenue Forecast

XAIR EPS Forecast

XAIR FAQs

What is bull’s view on XAIR?

XAIR stock has a bullish outlook due to its recent $200M mixed securities shelf filing, which enhances financial flexibility and supports growth initiatives. Analysts at JonesResearch have initiated a "Buy" rating with a $1 price target, citing potential revenue growth from the LungFit PH system's regulatory approvals in Australia and other markets. Despite prior challenges, the company is positioned for broader market adoption and revenue expansion.

What is bear's view on XAIR?

XAIR stock currently faces bearish sentiment due to its recent $200 million mixed securities shelf filing, which may dilute shareholder value. Analysts from JonesResearch have set a low price target of $1, reflecting concerns over the company's limited revenue growth despite regulatory approvals for its LungFit PH system. The stock's commercial challenges and financial flexibility issues further weigh on its outlook.